Over the last 7 days, the Australian market has risen 2.2%, and over the past 12 months, it is up 11%, with earnings forecast to grow by 13% annually. In this favorable environment, identifying high growth tech stocks like Nuix and others can be crucial for investors looking to capitalize on robust market conditions.
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Telix Pharmaceuticals | 20.85% | 38.76% | ★★★★★★ |
Clinuvel Pharmaceuticals | 22.48% | 26.75% | ★★★★★★ |
DUG Technology | 15.32% | 42.38% | ★★★★★☆ |
Megaport | 16.19% | 35.55% | ★★★★★☆ |
Doctor Care Anywhere Group | 23.44% | 96.41% | ★★★★★★ |
Enlitic | 104.77% | 94.35% | ★★★★★☆ |
Xero | 13.50% | 24.14% | ★★★★★☆ |
Mesoblast | 45.23% | 49.67% | ★★★★★★ |
Adveritas | 66.47% | 103.87% | ★★★★★★ |
SiteMinder | 20.26% | 70.41% | ★★★★★☆ |
Click here to see the full list of 52 stocks from our ASX High Growth Tech and AI Stocks screener.
Let’s uncover some gems from our specialized screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Nuix Limited offers investigative analytics and intelligence software solutions across various regions including Asia Pacific, the Americas, Europe, the Middle East, and Africa, with a market cap of A$1.42 billion.
Operations: Nuix Limited generates revenue from providing software solutions focused on investigative analytics and intelligence across multiple global regions. The company’s cost structure includes expenses related to software development, sales, and administrative functions.
Nuix reported a significant turnaround for the fiscal year ending June 30, 2024, with sales rising to AUD 220.62 million from AUD 182.47 million and net income reaching AUD 5.03 million compared to a net loss of AUD 5.59 million previously. The expanded partnership with Consilio underscores Nuix’s strategic positioning in data processing and eDiscovery services, leveraging its industry-leading software solutions to meet evolving client needs globally. With R&D expenses constituting approximately 13% of revenue, Nuix demonstrates its commitment to innovation and future growth potential within the high-growth tech sector in Australia.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Technology One Limited develops, markets, sells, implements, and supports integrated enterprise business software solutions in Australia and internationally with a market cap of A$7.37 billion.
Operations: Technology One Limited generates revenue primarily from software (A$317.24 million), corporate services (A$83.83 million), and consulting (A$68.13 million). The company operates both domestically in Australia and internationally, providing integrated enterprise business software solutions.
Technology One’s recent performance underscores its robust growth trajectory within Australia’s tech sector. For the half-year ending March 31, 2024, revenue surged to AUD 240.83 million from AUD 201.01 million previously, while net income grew to AUD 48 million from AUD 41.28 million. The company’s commitment to innovation is evident with R&D expenses accounting for approximately 11% of revenue, fueling advancements in their SaaS offerings and operational efficiencies under the new leadership of Paul Robson. With earnings projected to grow at an annual rate of 14.8%, Technology One demonstrates strong potential for sustained growth in a competitive market landscape.
Simply Wall St Growth Rating: ★★★★★☆
Overview: WiseTech Global Limited offers software solutions for the logistics execution industry across various regions including the Americas, Asia Pacific, Europe, Middle East and Africa, with a market cap of A$31.32 billion.
Operations: WiseTech Global Limited generates revenue primarily through its Internet Software & Services segment, amounting to A$939 million. The company serves the logistics execution industry across multiple regions including the Americas, Asia Pacific, Europe, Middle East and Africa.
WiseTech Global’s revenue is forecasted to grow at 18.7% annually, outpacing the Australian market’s 5.4%. Despite a recent -2.1% earnings growth, WiseTech projects a robust annual earnings increase of 24.2%, driven by strategic R&D investments accounting for $180 million AUD or approximately 12% of revenue in FY23. The company recently completed a follow-on equity offering worth $94.5 million AUD and continues to expand its global reach under stable leadership, with CFO Andrew Cartledge ensuring smooth transitions through FY25.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Discover if WiseTech Global might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com